Stay updated with breaking news from Kent tseng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share: SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ( Company ) announced today that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenged with the virus that causes COVID-19 (SARS-CoV-2), resulted in decreased inflammation in the lungs of animals treated with Tempol compared to controls. This is the first data demonstrating that Tempol, a novel antioxidant, can reduce inflammation in animals given the virus (SARS-CoV-2) that causes COVID-19. The group plans on submitting the publication to a peer review journal. Dr. Chien-Te Kent Tseng, Professor of the Department of Microbiology and Immunology and Director of GNL s SARS/MERS/COVID-19 Laboratory at UTMB, commented on these results: In our hamster COVID-19 model, pulmonary inflammation with cellular infiltrates and hemorrhage (mild-to-moderate) is triggered by SARS-CoV-2 infection. Treatme ....
COVID-19: Angina drug may be an effective treatment Written by Erika Watts on February 26, 2021 Fact checked by Hilary Guite, FFPH, MRCGP New research in cells shows the drug bepridil holds promise for treating COVID-19. filadendron/Getty Images A recent study shows that bepridil a drug approved by the Food and Drug Administration (FDA) for treating heart angina but currently voluntarily withdrawn due to cardiac side effects may be highly effective in treating COVID-19. The researchers tested 55 different FDA-approved medications. As many as 29 of these showed promise, and six were found to reduce activity of a crucial enzyme that helps the virus replicate. ....
Share A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB). The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition. The team’s leaders are College of Science professor Wenshe Ray Liu, professor and holder of the Gradipore Chair in the Department of Chemistry at Texas A&M, and Chien-Te Kent Tseng, professor and director of the SARS/MERS/COVID-19 Laboratory at UTMB. Liu also holds joint faculty positions in Texas A&M’s colleges of medicine and agriculture and life sciences. ....
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch. ....